A citation-based method for searching scientific literature




K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
Times Cited: 66




List of shared articles



Times cited

Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential.
Ariana A Entezari, Adam E Snook, Scott A Waldman. Expert Opin Ther Targets 2021
0

ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice.
Peng Li, Jieru E Lin, Adam E Snook, Scott A Waldman. Toxins (Basel) 2017
8

Computational analyses and prediction of guanylin deleterious SNPs.
William F Porto, Octávio L Franco, Sérgio A Alencar. Peptides 2015
17

Pendrin, a novel transcriptional target of the uroguanylin system.
Julia Rozenfeld, Osnat Tal, Orly Kladnitsky, Lior Adler, Edna Efrati, Stephen L Carrithers, Seth L Alper, Israel Zelikovic. Cell Physiol Biochem 2013
3

Current understanding of guanylin peptides actions.
Aleksandra Sindic. ISRN Nephrol 2013
17

GUCY2C molecular staging personalizes colorectal cancer patient management.
Jian P Gong, Stephanie Schulz, Terry Hyslop, Scott A Waldman. Biomark Med 2012
3

Molecular staging individualizing cancer management.
Alex Mejia, Stephanie Schulz, Terry Hyslop, David S Weinberg, Scott A Waldman. J Surg Oncol 2012
13

Molecular staging estimates occult tumor burden in colorectal cancer.
Alex Mejia, Stephanie Schulz, Terry Hyslop, David S Weinberg, Scott A Waldman. Adv Clin Chem 2010
3

GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.
Alex Mejia, Stephanie Schulz, Terry Hyslop, David S Weinberg, Scott A Waldman. Expert Rev Mol Diagn 2009
10